KANIKA JAGGI: Open Payments
NPI 1073954962 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 24 payments from 12 companies in 2025. Trend: 2023 $601 · 2024 $515 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $114 |
| Novo Nordisk Inc | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABBVIE INC. | 3 | $49 |
| Corcept Therapeutics | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Wegovy, AIRSUPRA, JARDIANCE, UBRELVY, Korlym, FREESTYLE LIBRE 3, Veozah.
Industry payments across IN — which companies pay providers there.
